Schroders

Alentis Therapeutics AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, focused on developing novel treatments for advanced liver diseases. Founded in 2019, the company aims to address conditions such as liver fibrosis, cirrhosis, and liver cancer, particularly targeting Claudin-1 positive tumors and organ fibrosis. Alentis employs a research platform that utilizes clinically relevant readouts and single-cell RNA sequencing of patient liver tissues, enabling the development of effective therapies to combat fibrosis and reverse the progression of these diseases. Through its innovative approach, Alentis Therapeutics seeks to improve outcomes for patients suffering from severe liver-related health issues.

Cera Care Limited specializes in providing home care services for elderly individuals, including elderly care, palliative care, respite care, post-discharge care, dementia care, and private nursing services. Established in 2015 and based in London, the company has expanded its reach across various regions in the United Kingdom, such as Hertfordshire, Bedfordshire, and Oxfordshire. Cera employs a digital platform that features a matching algorithm and automated scheduling systems, allowing for efficient home care arrangements within 24 hours. This innovative approach reduces overhead costs compared to traditional care providers, enabling Cera to offer competitive rates while paying its caregivers above the industry average. As a result, the company attracts experienced and well-trained carers committed to delivering high-quality care tailored to the individual needs and preferences of their clients. Cera Care Limited was formerly known as Golden Era Club Ltd before rebranding in July 2018.

Forteus is an asset manager focused on blockchain technology and digital assets.

Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, specializing in the discovery and early development of small molecules targeting G Protein-Coupled Receptors (GPCRs). Founded in 2001, the company focuses on developing therapeutics for Central Nervous System diseases and cancer. It employs innovative technologies, including its proprietary DTect-All platform, which identifies both orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs). This platform is particularly adept at addressing challenging GPCRs, such as orphan and peptidic receptors. Additionally, Domain Therapeutics offers BioSens-All, a platform designed to explore the signaling complexity associated with GPCR activation. The company, formerly known as Faust Pharmaceuticals SA, rebranded in December 2008 to reflect its focus on GPCR-targeted therapeutics.

Redcliffe LifetechRedcliffe Lifesciences specializes in reproductive health testing, rare diseases, and cancer genetic diagnostics. The company offers a wide range of advanced products and services for healthcare companies, research institutions, and other public and private partnerships, such as testing using molecular and gene-based diagnostics, therapeutic molecules and advanced therapies, next-generation sequencing, and all bioinformatics services.

Healthy Workers B.V. engages in the development of B2B solutions to create healthy working environment for organizations. The company's products include WELLBEING-SCAN and an employer dashboard that enable employers to measure, analyze, and take measures to improve the well-being of their employees. The company engages in providing consultancy services on productivity, stress, engagement, well-being, and stressors in the workplace. The company was founded in 2016 and is headquartered in Amsterdam, the Netherlands.

IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.

Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Established in 2019, Eikon utilizes advanced super-resolution microscopy techniques, enabling real-time, molecular-resolution measurements of protein movement in living cells. This unique discovery platform allows the company to target previously difficult-to-address biological targets, leveraging groundbreaking innovations from its founders, including a Nobel Prize recipient. Through these efforts, Eikon aims to create novel therapeutics that address unmet medical needs.

Ambys Medicines, Inc. is a biotechnology company based in Redwood City, California, founded in 2016. The company focuses on discovering and developing innovative therapies for severe liver diseases. Its approach includes gene therapy, drug therapy, and cell therapy, aiming to restore liver function, halt the progression of liver disease, and address the serious complications associated with liver failure. Through its research and development efforts, Ambys Medicines seeks to significantly improve the quality of life for individuals affected by liver-related health issues.

AgroStar is India’s foremost AgTech start-up working on the mission of #HelpingFarmersWin by providing a complete range of agri solutions at the fingertips of farmers. AgroStar’s tech platform provides a combination of agronomy advice coupled with service and agri input products that enable farmers to significantly improve their productivity and income. We use an extensive amount of data, technology and agronomy knowledge to give the right solutions (advice+products) to Indian farmers. AgroStar currently operates in the states of Gujarat, Maharashtra, and Rajasthan and has over 5 Lakh farmers on its digital platform. Farmers in these states can avail agri solutions for their entire crop life-cycle with a simple “missed call” or through its Android app, which is amongst the highest rated farming focused apps in the country. Over the next 5 years, we plan to continue to provide incremental value to farmers in terms of wide range of inputs delivered at their doorsteps, world-class agronomy guidance and also access to market linkages and credit.

Artios Pharma Limited is a biotechnology company based in Cambridge, United Kingdom, focused on developing innovative cancer treatments that target DNA damage response (DDR) pathways. Founded in 2015, the company aims to create first-in-class therapies that selectively kill cancer cells by exploiting the mechanisms involved in DNA repair. Its product pipeline features several promising candidates, including DNA polymerase theta (Polθ) and an in-licensed program targeting a novel DDR protein. Artios collaborates with Cancer Research Technology and leading researchers in the field to advance its development efforts. The company's leadership comprises experts with extensive experience in DDR drug discovery, and it has garnered investment from notable entities, including SV Life Sciences and AbbVie Ventures.

CeQur SA is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to comply with therapy and stay in control of their disease. CeQur is developing the CeQurâ„¢ Insulin Infuser, a simple and discrete insulin delivery tool for people who could benefit from intensive insulin therapy but want flexibility and freedom from multiple daily injections. CeQur was established in January 2008 as a spin out from Danfoss A/S, a large, global Danish industrial products group. The company is headquartered in Montreux, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.

Graphcore Limited, a hardware systems company develops intelligent processing units. It offers IPU-Accelerator cards, which can be plugged into a server to accelerate machine-learning applications; and IPU-Appliance products that provide enhanced performance to deliver inference systems supporting various users or provide faster training. Graphcore Limited was incorporated in 2016 and is based in Bristol, United Kingdom with additional locations in Palo Alto, California; London, United Kingdom; Oslo, Norway; and Beijing, China.

Pamfleet Group is a real estate investment firm. The firm seeks to invest in residential and commercial properties in Hong Kong and Singapore. It typically targets B-Grade commercial real estate with repositioning or redevelopment potential. Pamfleet Group was founded in 2000 and is based in Hong Kong, with an additional office in Singapore. As a result of the acquisition of Schroders plc, Pamfleet Group's name was changed. As of July 31, 2020, Schroder Pamfleet operates as a subsidiary of Schroders plc.

BlueOrchard Finance S.A. is a prominent asset manager specializing in impact investing, particularly through debt financing for microfinance institutions globally. Founded in 2001 and headquartered in Geneva, Switzerland, the firm has established local offices in several countries, including Cambodia, Georgia, Peru, and Kenya. BlueOrchard focuses on providing innovative financing solutions in emerging markets, with a commitment to socially responsible financial inclusion. Since its inception, the company has facilitated over USD 2 billion in loans to microfinance institutions, targeting sectors that deliver direct social and environmental benefits. Its private equity arm, BlueOrchard Investments Sàrl, invests in growth capital for mid-sized companies and projects related to renewable energy, energy efficiency, and waste management, typically allocating between USD 3 million and USD 15 million in debt or equity. Through its efforts, BlueOrchard aims to empower underserved communities, improve living standards, and generate attractive financial returns for its investors.

Blue Asset Management is a full-service investment manager for commercial real estate. Integrity, professionalism, reliability and a consistent focus on client needs are the core values on which the company vision is based on. They strive for long-term and trusted relationships with their clients and business partners. An active, honest and transparent information policy characterizes their cooperative relationship approach of the business.

Thirdrock Group - Wealth management business provides wealth management services.

Qwil Messenger solves the challenge of making chat safe and compliant when it matters most: between staff, clients and partners. Our platform approach, with one unique instant messaging app (Qwil Messenger) and entry point for both clients and staff of multiple firms and their brands globally, is supported by complex and proprietary technology design. This allows us to deploy our servers rapidly across multi-jurisdictions and host to almost any data centre, in any location (or locations), at low cost and with instant scalability. Qwil Messenger also has 200 end points enabling integration and automation as business needs evolve.

WeInvest is an online platform that enables individual investors to discover investment opportunities across real estate, mutual funds, and deposits. Users can get investment ideas, find products that fit their ideas, track their investment portfolios, and connect with prospective brokers and advisors. WeInvest was launched in 2013 and is based in Singapore.

Algonquin SA, based in Brussels, Belgium, specializes in the investment, ownership, operation, and franchising of hotels across Europe. Founded in 1998, the company currently manages 43 hotel assets, offering over 7,500 rooms with a combined value of €1.8 billion. Approximately half of these properties operate under Algonquin's own brands or renowned international franchises, while the remainder is managed through agreements with major international operators. What distinguishes Algonquin is its dual role as both an investor and an operator, enabling active involvement in hotel operations. This includes oversight of daily management functions, human resources, sales and marketing strategies, and regulatory compliance, as well as real estate management through in-house project expertise and capital expenditure programs. As a result, Algonquin has attracted investments from institutional investors, family offices, and private equity firms into various dedicated investment vehicles.

Adveq, founded in 1997 and now known as Schroder Adveq, is a prominent asset manager specializing in private equity and real asset investments on a global scale. Headquartered in Zurich, the firm provides tailored investment solutions that enable clients to access targeted segments of private markets. Adveq has invested in over 400 funds, consistently delivering strong returns across various economic cycles. Its clientele primarily consists of institutional investors, including pension funds, insurance companies, family offices, and other financial institutions from Europe, North America, and the Asia-Pacific region. The firm has cultivated long-term relationships with many investors, earning a reputation as a trusted partner in private market investing. Adveq operates offices in major financial centers, including Frankfurt, London, New York, Beijing, Shanghai, and Hong Kong, and maintains an agent relationship in Sydney.

Nutmeg Saving and Investment Limited, commonly known as Nutmeg, is an online investment management firm based in London, United Kingdom. Established in 2011, Nutmeg provides clients with portfolio management services, helping them make informed investment decisions related to equities, corporate bonds, gilts, and gold. The company specializes in various investment vehicles, including ISAs and pensions, and is recognized as the first wealth manager in the UK to offer a six-year performance track record. Nutmeg aims to simplify money management for individuals through its intelligent and straightforward approach to investing.

Benchmark Capital, established in 2015, focuses on enhancing the growth and success of firms in the financial services sector. The company offers a comprehensive suite of digital wealth management solutions that equip financial advisers with insights, integrated tools, and investment services to enhance their client offerings. By uniting various components of the fragmented industry, Benchmark Capital provides best-in-class technology solutions and discretionary platforms. This approach delivers competitive advantages to over 120 prominent national and regional firms, positioning them for greater success in the marketplace.

CeQur SA is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to comply with therapy and stay in control of their disease. CeQur is developing the CeQurâ„¢ Insulin Infuser, a simple and discrete insulin delivery tool for people who could benefit from intensive insulin therapy but want flexibility and freedom from multiple daily injections. CeQur was established in January 2008 as a spin out from Danfoss A/S, a large, global Danish industrial products group. The company is headquartered in Montreux, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.

Nutmeg Saving and Investment Limited, commonly known as Nutmeg, is an online investment management firm based in London, United Kingdom. Established in 2011, Nutmeg provides clients with portfolio management services, helping them make informed investment decisions related to equities, corporate bonds, gilts, and gold. The company specializes in various investment vehicles, including ISAs and pensions, and is recognized as the first wealth manager in the UK to offer a six-year performance track record. Nutmeg aims to simplify money management for individuals through its intelligent and straightforward approach to investing.

Cazenove Capital is a leading provider of personalised wealth management services to private clients, family offices, trusts, companies and pension plans. As a long-established wealth manager with an absolute focus on preserving and growing their clients’ wealth, what matters most to their clients, matters most to them. Private individuals, family offices, trusts, businesses and pension plans all rely on them to provide them with bespoke, discretionary and advisory investment services. Skilled in investment management, wealth planning and banking services – they also offer discretionary fund management to external advisers and their clients, and they are a leading charity fund manager in the UK. Their experience of navigating complex markets and adapting to change, helps them balance risk and reward. The investment expertise they call upon as part of a truly global asset manager, combined with their long-standing experience of advising clients, is what sets them apart.

STW Fixed Income Management Ltd. is an employee owned investment manager with approximately $11 billion in assets under management. The firm provides its services to pensions, foundations, endowments, family wealth companies, insurance companies, nuclear decommissioning trusts, and settlement trusts. It manages separate client focused fixed income portfolios. The firm invests in the public fixed income markets of the United States. It prefers to invest in technology sectors including technical infrastructure and software development sectors. The firm invests only in investment grade fixed income value securities.

GeoSentric's GyPSii is the market-leading mobile digital lifestyle application and geo-mobility social networking platform: connecting people, places and communities across networks and devices, with patented technologies for the transfer and publishing of location based information between mobile devices. Based in Salo, Finland and Amsterdam, The Netherlands, GeoSentric operates offices in North America, Europe and Asia Pacific. GeoSentric is listed on the Nordic Exchange (NASDAQ OMX: GEO1V)).

CeQur SA is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to comply with therapy and stay in control of their disease. CeQur is developing the CeQurâ„¢ Insulin Infuser, a simple and discrete insulin delivery tool for people who could benefit from intensive insulin therapy but want flexibility and freedom from multiple daily injections. CeQur was established in January 2008 as a spin out from Danfoss A/S, a large, global Danish industrial products group. The company is headquartered in Montreux, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.

GeoSentric's GyPSii is the market-leading mobile digital lifestyle application and geo-mobility social networking platform: connecting people, places and communities across networks and devices, with patented technologies for the transfer and publishing of location based information between mobile devices. Based in Salo, Finland and Amsterdam, The Netherlands, GeoSentric operates offices in North America, Europe and Asia Pacific. GeoSentric is listed on the Nordic Exchange (NASDAQ OMX: GEO1V)).

Orthomimetics was founded in 2005 as a spin-out from the University of Cambridge and the Massachusetts Institute of Technology (MIT). Its products are based on a leading collagen biomaterials platform for the production of scaffolds for cartilage, meniscus, ligament and tendon repair. Orthomimetics’ flagship product, Chondromimetic™, is an off-the-shelf, resorbable implant for the minimally invasive repair of small osteochondral (cartilage and underlying bone) defects. The product has received European market approval (CE-Mark approval) and is close to entering the European market. Small osteochondral defects represent an important medical need that is currently not covered by TiGenix’ products. Chondromimetic™ forms an excellent fit with TiGenix’ lead product, ChondroCelect®, since both products target the same customer base in complementary indications.

Newfinance Capital is a London-based funds of hedge funds manager.

Square Enix is a prominent developer, publisher, and distributor of interactive entertainment, known for its influential contributions to the gaming industry. The company produces a wide array of digital content, including online games, mobile applications, music, and DVDs. Notable franchises under its umbrella include Final Fantasy, Dragon Quest, Tomb Raider, and Deus Ex, among others. Square Enix also offers services such as PlayOnline, a cross-platform online community, and multiplayer online role-playing games accessible on various platforms. Founded in 1989 and headquartered in El Segundo, California, Square Enix operates with a European corporate headquarters in London, supporting its extensive business operations across multiple roles. Additionally, the company encompasses Eidos Interactive, which is home to renowned game properties like Hitman and Just Cause, further enhancing its portfolio of intellectual properties.

CellZome is a pharmaceutical company that discovers, develops, and commercializes kinase-targeted drugs for the treatment of inflammatory diseases. It develops a pipeline of kinase inhibitors targeting inflammatory mediators as oral therapeutics for rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, psoriasis, and asthma. CellZome was founded in 2000 and is based in Heidelberg, Baden-Wurttemberg.

Founded in 1997, icollector.com was one of the pioneers in bringing auctioneers together with interested buyers. Today, we have over 1000 auction house clients worldwide, among them the top auction houses and licensed dealers in their respective categories. We specialize and excel in coin auctions, vintage collectibles, gaming memorabilia, collectible firearms, movie props and original set costumes. Furthermore, our clients excel in placing native memorabilia, original prints and paintings as well as vintage and one of a kind jewellery and diamonds. Our main service offering is pay per use access to our platform icollector.com on which we list our client’s items for sale in a catalogue order to coincide with the physical auction at the location and date they chose. Our software tools and reporting suite let interested bidders register for a free account online, place bids raise or alter bids on as many items they like and ultimately bid live in real time against hundreds of other bidders on the auction floor or around the world. Having run over 10,000 auctions since our inception, we can draw from a deep and well structured database of past bidders, auction item stats, sold prices and other useful information for bidders and dealers alike. Coupled with innovative marketing using a combination of email marketing, social media and traditional vehicles to reach bidders, we are a full service firm focused on doing the best things to help our customers grow in their business. Before, during and after each auction, we offer full auction house support. This ranges from reporting functions such as geo targeting of bidders and marketing efforts to credit approval payment and shipping integration to facilitate and automate as many functions of our client’s operations as possible. Icollector.com also has shared functions with its sister platform www.liveauctionworld.com which is mainly used to promote industrial and commercial sales at auction. Icollector.com also belongs to the same group of brands that operates www.liveauctiongroup.com, which is a custom software builder for the auction industry, lending a client a unique and powerfully branded platform while giving them full access to all the major tools and reports the auction industry relies on for its success.